Bill > HR863

This bill, the DXM Abuse Prevention Act of 2019, amends the Federal Food, Drug, and Cosmetic Act to prevent the abuse of dextromethorphan (DXM), a common ingredient in over-the-counter cough medicines. The key provisions include: 1) Requiring retailers selling DXM-containing drugs to have a verification system to ensure the purchaser is at least 18 years old, with civil penalties for non-compliance. 2) Restricting the possession, receipt, or distribution of unfinished dextromethorphan, except for registered pharmacies, drug researchers, and manufacturers. The bill aims to curb the recreational abuse of DXM, particularly among younger consumers, by implementing age verification measures and limiting access to the raw ingredient.